This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Analysts' Actions: CBST EOG LRN MRK PFE

Stocks in this article: CBSTEOGLRNMRKPFE

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Abercrombie & Fitch (ANF) was downgraded to hold at TheStreet Ratings.

Cubist (CBST) was upgraded at Mizuho to buy from neutral. $77 price target. Acquisitions should help drive near-term growth, Mizuho said.

C&J Energy (CJES) was downgraded at Cowen to market perform from outperform. $22.30 price target. Fracturing services market continues to suffer from chronic oversupply, Cowen said.

Ellington Financial (EFC) was upgraded to hold at TheStreet Ratings.

EOG Resources (EOG) was upgraded at Credit Suisse to outperform from neutral. $175 price target. Estimates were also increased, given higher oil production forecasts, Credit Suisse said.

Iberiabank (IBKC) was downgraded at Oppenheimer to perform from outperform. Company is seeing pressure in mortgage banking, Oppenheimer said.

K12 (LRN) was downgraded at Robert Baird to neutral from outperform. $25 price target. Company slashed its guidance, Baird said.

K12 was downgraded at BMO Capital to market perform from outperform. $22 price target. Company is seeing lower enrollment growth, BMO Capital said.

Masco (MAS) was upgraded at J.P. Morgan to overweight from neutral. $21 price target. Valuation is reasonable against unaggressive 2015 estimates, J.P. Morgan said.

Merck (MRK) was initiated with a neutral rating at Credit Suisse. $49 price target. Core franchises are facing growth challenges, Credit Suisse said.

Owens Corning (OC) was upgraded at J.P. Morgan to overweight from neutral. $45 price target. More constructive view on repair/remodel focused building product names, J.P. Morgan said.

Pfizer (PFE) was initiated with an outperform rating at Credit Suisse. $34 price target. Restructuring story will likely continue to evolve, Credit Suisse said.

Patterson-UTI (PTEN) was downgraded at Cowen to perform from outperform. $24 price target. Pressure pumping prices will likely show no improvement, Cowen said.

Viropharma (VPHM) was downgraded at Mizuho to neutral from buy. Valuation call, based on a $39 price target, Mizuho said.

Stock Comments / EPS Changes

Hain Celestial (HAIN) estimates were cut at Jefferies through 2013. Guidance below consensus at analyst day, Jefferies said. Buy rating and $91 price target.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs